A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease

Cailin H. Sibley, Andrea Chioato, Sandra Felix, Laurence Colin, Abhijit Chakraborty, Nikki Plass, Jackeline Rodriguez-Smith, Carmen Brewer, Kelly King, Christopher Zalewski, H. Jeffrey Kim, Rachel Bishop, Ken Abrams, Deborah Stone, Dawn Chapelle, Bahar Kost, Christopher Snyder, John A. Butman, Robert Wesley, Raphaela Goldbach-Mansky